Wearable and Lab Data Integration for Cross-Signal Investigation

The buyer problem

More data has made interpretation harder for precision-health clinics and digital-health programmes.

Wearables produce dense, vendor-specific time series while laboratories produce sparse, clinically governed observations. Naively joining them creates false precision.

The answer is not another isolated dashboard. It is a governed way to evaluate change across time and modalities, preserve what each source can and cannot establish, and make the underlying evidence available for review.

Interpretation discipline

Evidence before certainty

Vizier should make complex data easier to investigate without making the evidence stronger than it is. A temporal relationship is not automatically causal. A genetic association is not a diagnosis. Movement in a surrogate biomarker is not necessarily a clinical outcome.

Findings should retain source, timing, reference context and confidence. Where modalities disagree, data is missing, or follow-up is too short, the useful answer is often that the evidence is insufficient.

The distinctions that matter

• Association is not causality; timing and confounding still matter.
• Genetic predisposition is not the same as expressed phenotype.
• Biomarker movement is not automatically a clinical outcome.
• A biological-age estimate is model output, not a lifespan prediction.